Protein influence on early heart development could lead to better regenerative therapies

April 5, 2017
Protein influence on early heart development could lead to better regenerative therapies
Studies of heart development in zebrafish embryos could lead to new stem cell therapies. Credit: Philipp Keller, Bill Lemon, Yinan Wan and Kristin Branson, Janelia Farm Research Campus, Howard Hughes Medical Institute, Ashburn, Va. 

Stem cell therapies could one day help repair heart tissue in people with cardiovascular disease. But before doctors feel confident enough to transplant these potent cells into patients, they need to better understand how heart stem cells work normally in the developing embryo. A team of researchers from Singapore and Canada have shown that a receptor needed for early heart development works through intermediate signaling molecules to modulate the activity of a key determinant of cell fate.

A detailed understanding of this molecular cross-talk could help in the derivation of specific cell types from human for regenerative medicine, says Bruno Reversade, a human geneticist at the A*STAR Institute of Medical Biology, who co-led the investigation.

The zebrafish has emerged as a powerful scientific model for studying and function. From the outside, the differences between the hearts of zebrafish and humans may seem substantial, but the two species have strong similarities at the genetic and morphological levels. Because zebrafish embryos are transparent, they provide a tractable system for watching heart development in action.

Reversade teamed up with Ian Scott from the University of Toronto to examine the link between zebrafish born with no heart due to a mutation in a gene that encodes a cell-surface GPCR called the Apelin receptor. They knew that these fish had defective heart stem cells, but it wasn't clear why.

The researchers looked into the expression of genes targeted by another protein called Nodal, a known master regulator of . They found that zebrafish without a working Apelin receptor had lower levels of Nodal target gene expression at the stage of embryonic formation when Nodal activity would normally induce heart stem cells to form. However, experimentally elevating levels of the Apelin receptor increased the expression of these same targets. What's more, directly boosting Nodal activity in zebrafish that lacked the Apelin receptor was sufficient to help them develop beating hearts.

The Apelin receptor and Nodal don't seem to be working in the same , though. As Reversade and Scott showed, the Apelin receptor modulated Nodal signaling through two Nodal ligands, called Squint and Cyclops. Thus, the Apelin receptor seems to serve as kind of a distant rheostat for fine-tuning the Nodal pathway during the earliest stages of heart development.

Future research will help determine how turning the knob on the expression level of the Apelin receptor can aid human patients with congenital diseases.

Explore further: Novel hormone essential for heart development discovered

More information: Ashish R Deshwar et al. The Apelin receptor enhances Nodal/TGFβ signaling to ensure proper cardiac development, eLife (2016). DOI: 10.7554/eLife.13758

Related Stories

Novel hormone essential for heart development discovered

December 6, 2013
Scientists at A*STAR's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat ...

Researchers uncover a hormone that plays a vital role in heart development

March 12, 2014
Hormones—regulatory biochemicals produced by the body—were first identified over 100 years ago. Since then, improvements in researchers' understanding of the key role that hormones play as chemical messengers in processes ...

New insights into the development of the heart

March 26, 2013
Viewed from the outside, our body looks completely symmetrical. However, most internal organs – including the heart – are formed asymmetrically. The right side of the heart is responsible for pulmonary circulation; the ...

Researchers find the link between heart and blood cells in early development

October 7, 2016
New research from the University of Minnesota reveals endoglin as a critical factor in determining the fate of early undifferentiated cells during development. Endoglin, a receptor involved in cell signaling, has previously ...

Recommended for you

Half of people aged 40-54 have hardened arteries: study

December 11, 2017
Half of middle-aged people who are normal weight and don't smoke or have diabetes may have clogged arteries, researchers said Thursday, urging stronger measures to lower cholesterol.

Research suggests new pathways for hyperaldosteronism

December 7, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), in collaboration with researchers at Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the ...

One-dose gene therapy produces clotting factor, safely stops bleeding in hemophilia B patients

December 6, 2017
A team of gene therapy researchers has reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B. A single intravenous infusion of a novel bioengineered gene therapy treatment ...

Clot-busting drugs not recommended for most patients with blood clots

December 6, 2017
Not all patients with blood clots in their legs - a condition known as deep vein thrombosis - need to receive powerful but risky clot-busting drugs, according to results of a large-scale, multicenter clinical trial.

Mitochondrial protein in cardiac muscle cells linked to heart failure, study finds

December 5, 2017
Reducing a protein found in the mitochondria of cardiac muscle cells initiates cardiac dysfunction and heart failure, a finding that could provide insight for new treatments for cardiovascular diseases, a study led by Georgia ...

Blood pressure declines 14 to 18 years before death

December 4, 2017
Blood pressure in the elderly gradually begins to decrease about 14 or so years before death, according to a new study published today in the JAMA Internal Medicine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.